UPMC Hillman Cancer Center Passavant North — Cranberry Township, Pennsylvania

UPMC Hillman Cancer Center Passavant North is a clinical research site located in Cranberry Township, Pennsylvania, United States 16066.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

UPMC Hillman Cancer Center Passavant North has participated in 1 clinical trials.

Therapeutic areas: HER2 Positive Breast Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UPMC Hillman Cancer Center Passavant North?

UPMC Hillman Cancer Center Passavant North has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UPMC Hillman Cancer Center Passavant North conducted?

UPMC Hillman Cancer Center Passavant North has 1 clinical trials on record. Their work covers HER2 Positive Breast Cancer.

Is UPMC Hillman Cancer Center Passavant North accredited by Crixeo Health?

UPMC Hillman Cancer Center Passavant North has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UPMC Hillman Cancer Center Passavant North?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.